Bessemer Group Inc. Increases Stake in Intuitive Surgical, Inc. $ISRG

Bessemer Group Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 967,778 shares of the medical equipment provider’s stock after purchasing an additional 179,450 shares during the quarter. Bessemer Group Inc. owned approximately 0.27% of Intuitive Surgical worth $432,821,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Tobam grew its holdings in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical during the 2nd quarter worth $27,000. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical during the 3rd quarter valued at about $27,000. Princeton Global Asset Management LLC acquired a new position in Intuitive Surgical during the 2nd quarter valued at about $30,000. Finally, Guerra Advisors Inc purchased a new stake in Intuitive Surgical in the third quarter valued at about $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Myriam Curet sold 126 shares of the stock in a transaction that occurred on Thursday, January 29th. The stock was sold at an average price of $520.02, for a total value of $65,522.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $531.52, for a total value of $1,488,256.00. Following the transaction, the director owned 15,720 shares in the company, valued at approximately $8,355,494.40. This represents a 15.12% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 73,616 shares of company stock valued at $40,929,575 in the last three months. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $478.49 on Thursday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $609.08. The firm’s fifty day moving average is $553.29 and its 200 day moving average is $510.97. The firm has a market cap of $171.53 billion, a PE ratio of 60.65, a P/E/G ratio of 3.72 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.21 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on ISRG shares. The Goldman Sachs Group restated a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a report on Friday, January 9th. Robert W. Baird cut their price target on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. Piper Sandler reiterated an “overweight” rating and set a $620.00 price objective (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, January 17th. Finally, Raymond James Financial raised their target price on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $620.41.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.